Quantoom Biosciences

Quantoom Biosciences is a private, pre-revenue platform and services company providing an integrated RNA manufacturing toolbox called N-Force. Its platform comprises three core technologies: Ncode for sequence design, Ntensify® for RNA production, and Ncapsulate® for LNP formulation, aiming for >10x improvements in speed and cost over conventional methods. The company partners with biopharma organizations to de-risk and accelerate their RNA drug development programs from preclinical stages onward. Based in Gosselies, Belgium, Quantoom is positioned as an enabler in the rapidly expanding RNA therapeutics and vaccines sector.

N-Force toolbox: an integrated platform comprising Ncode (bioinformatics for sequence design), Ntensify® (construct-agnostic RNA production process), and Ncapsulate® (LNP formulation chemistry and process) for end-to-end (sa)mRNA-LNP drug product development.

Quantoom competes with large, established Contract Development and Manufacturing Organizations (CDMOs) like Lonza and Catalent, as well as other technology-focused firms such as Strand Therapeutics, Replicate Bioscience, and Arbor Biotechnologies. Its differentiation lies in offering a proprietary, integrated end-to-end stack rather than individual services or components.